Fig. 6.
Positive correlation between the number of IFN-γ-secreting cells and cytolytic activity in CTL lines.
EBV-specific CTL lines from 4 HLA-A2 donors were generated by weekly restimulation with irradiated autologous LCLs for 2 to 4 weeks. The CTL lines were then assayed as responders/effectors in a paired ELISPOT/51Cr-release assay. Stimulators for the ELISPOT assay or targets for 51Cr-release assay included autologous LCLs for both the ELISPOT and 51Cr-release assays (filled diamonds), autologous PBMCs in medium containing peptide (LMP2 or BMLF1 peptide) as stimulators for ELISPOT assays, and autologous PHA blasts in medium containing peptide as targets for 51Cr-release assay (open diamonds).